On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 1% of all podcasts globally, and On The Pen is a top Substack best-seller.
Categories: Health & Fitness, News
Tags: cagrisema, mounjaro, obesity, Orforglipron, ozempic, retatrutide, Rybelsus, Wegovy, zepbound
Looking for real information on GLP-1 medications and weight loss? You’re in the right place.
The Plus SideZ Podcast is your go-to space for science-backed conversations about obesity treatment, weight loss, and living with a chronic metabolic disorder. Hosted by Kim Carlos and Kat Carter, we explore GLP-1 medicationslike Ozempic, Wegovy, Mounjaro, and Zepbound, featuring insights from leading obesity specialists, endocrinologists, and bariatric surgeons. But this podcast is about more than just medication—it’s about navigating the mental, emotional, and physical journey of reclaiming your health.
We combat misinformation with education from top experts, helping you think critically about the latest research, treatment options, and systemic challenges in obesity care. And at the heart of it all are the powerful, vulnerable stories of our brave community members—people sharing their real experiences on GLP-1 medications, breaking stigma, and taking control of their health.
Ranked in the top 1% of podcasts globally, The Plus SideZ Podcast has won three awards in just 18 months, including two Anthem Awards for social impact. Featured on Good Morning America, Bloomberg News, and ABC Nightline on Hulu, we’re at the forefront of the conversation on weight loss, obesity care, and the fight to end weight bias.
Join us and be part of a movement that’s changing the way the world understands obesity, health, and metabolic wellness.
Want to donate?
PayPal
https://www.paypal.com/donate/?hosted_button_id=ZSEE2DRPHDSZN
GoFundMe
https://gofund.me/82c8138e
Shop The Plus SideZ Merch Store
https://the-plus-sidez-podcast.printify.me/products/1
Website
https://theplussidez.com/
Categories: Education, Health & Fitness
Tags: glp1, mounjaro, ozempic, saxenda, semaglutide, tirzepatide, victoza, Wegovy, weight loss, zepbound
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
Categories: Health & Fitness, News
Tags: cagrisema, glp1, health, Health & Fitness, health and wellness, Medicine, obesity, Orforglipron, ozempic, retatrutide, Rybelsus, Wegovy, zepbound